ELAN
Elanco Animal Health Incorporated$23.06-0.20 (-0.88%)Prev Close$23.24·MCap$11.52B·P/E—·Vol2.02M·Yield—
▲
Buys (12M)
11
$2.61M
▼
Sells (12M)
1
$100.0K
◆
Net Activity
Net Buyer
$2.51M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Elanco Animal Health Incorporated (ELAN) has been dominated by buying, with 11 insider purchases totaling $2.61M and 1 insider sale totaling $100.0K. The most recent insider transaction was by Bettington Timothy J (officer: SEE REMARKS), who sold $100.0K worth of shares on Oct 19, 2026. Elanco Animal Health Incorporated operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $11.52B.
ELAN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Bettington Timothy J | officer: SEE REMARKS | Sell | 4,350 | $23.00 | $100.0K | 138,911 |
| Aug 21, 2026 | Kurzius Lawrence Erik | director | Buy | 40,000 | $23.40 | $935.9K | 188,647+27% |
| Aug 18, 2026 | O'Neill Shiv | officer: GC AND CORP SEC | Buy | 3,998 | $23.58 | $94.3K | 87,832 |
| Aug 13, 2026 | Harrington Michael J | director | Buy | 5,000 | $21.82 | $109.1K | 131,451 |
| Aug 10, 2026 | VanHimbergen Robert M | officer: EVP and CFO | Buy | 4,200 | $23.08 | $96.9K | 137,516 |
| Aug 10, 2026 | Herendeen Paul | director | Buy | 10,000 | $23.69 | $236.8K | 111,687 |
| May 19, 2026 | Modi Rajeev A. | officer: SEE REMARKS | Buy | 4,911 | $20.35 | $99.9K | 160,812 |
| May 19, 2026 | Simmons Jeffrey N | director, officer: PRESIDENT, CEO AND DIRECTOR | Buy | 4,971 | $20.09 | $99.8K | 171,971 |
| Dec 12, 2025 | Kurzius Lawrence Erik | Director | Buy | 10,000 | $21.30 | $213.0K | 0 |
| Dec 11, 2025 | Modi Rajeev A. | SEE REMARKS | Buy | 4,500 | $21.33 | $96.0K | 0 |
| Dec 11, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 22,000 | $21.75 | $478.5K | 0 |
| Dec 11, 2025 | VanHimbergen Robert M | EVP and CFO | Buy | 6,950 | $21.64 | $150.4K | 0 |
| Jul 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,346 | $14.64 | $63.6K | 0 |
| Jul 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,161 | $14.64 | $17.0K | 0 |
| Apr 3, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 23,558 | $9.72 | $229.0K | 0 |
| Mar 7, 2025 | Kurzius Lawrence Erik | Director | Buy | 20,000 | $10.55 | $211.0K | 0 |
| Mar 5, 2025 | HOOVER R DAVID | Director | Buy | 25,000 | $10.90 | $272.6K | 0 |
| Mar 1, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 3,514 | $11.17 | $39.3K | 0 |
| Mar 1, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 11,749 | $11.17 | $131.2K | 0 |
| Mar 1, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 4,747 | $11.17 | $53.0K | 0 |
| Mar 1, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 15,049 | $11.17 | $168.1K | 0 |
| Mar 1, 2025 | Kinard David S | SEE REMARKS | Sell | 7,162 | $11.17 | $80.0K | 0 |
| Mar 1, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 3,430 | $11.17 | $38.3K | 0 |
| Mar 1, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,356 | $11.17 | $26.3K | 0 |
| Mar 1, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 6,557 | $11.17 | $73.2K | 0 |
| Mar 1, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 3,879 | $11.17 | $43.3K | 0 |
| Mar 1, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 75,721 | $11.17 | $845.8K | 0 |
| Mar 1, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 18,196 | $11.17 | $203.2K | 0 |
| Feb 19, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 30,093 | $11.24 | $338.2K | 207,169 |
| Feb 19, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 11,808 | $11.24 | $132.7K | 64,042 |
| Feb 19, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 69,916 | $11.24 | $785.9K | 186,214-27% |
| Feb 19, 2025 | Kinard David S | SEE REMARKS | Sell | 17,968 | $11.24 | $202.0K | 173,935 |
| Feb 19, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 2,596 | $11.24 | $29.2K | 55,641 |
| Feb 19, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,691 | $11.24 | $30.2K | 49,462 |
| Feb 19, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 18,737 | $11.24 | $210.6K | 94,619 |
| Feb 19, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 2,943 | $11.24 | $33.1K | 26,849 |
| Feb 19, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 195,840 | $11.24 | $2.20M | 1,612,848 |
| Feb 19, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 46,045 | $11.24 | $517.5K | 159,062 |
| Jan 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 351 | $11.98 | $4.2K | 50,212 |
| Jan 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 414 | $11.98 | $5.0K | 48,773 |
| Aug 22, 2024 | Harrington Michael J | Director | Buy | 3,500 | $14.85 | $52.0K | 81,094 |
| Aug 12, 2024 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 100,000 | $13.01 | $1.30M | 145,000+222% |
| Jul 3, 2024 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,345 | $14.13 | $61.4K | 50,563 |
| Jul 3, 2024 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,160 | $14.13 | $16.4K | 49,187 |
| May 21, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.98 | $254.7K | 76,330 |
| Apr 3, 2024 | Bettington Timothy J | SEE REMARKS | Sell | 23,557 | $15.43 | $363.5K | 106,387 |
| Apr 1, 2024 | Modi Rajeev A. | SEE REMARKS | Sell | 7,509 | $15.97 | $119.9K | 69,763 |
| Mar 8, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.30 | $244.5K | 61,330+32% |
| Mar 8, 2024 | Harrington Michael J | Director | Buy | 3,100 | $16.29 | $50.5K | 77,594 |
| Mar 6, 2024 | HOOVER R DAVID | Director | Buy | 20,000 | $16.14 | $322.8K | 185,000 |
Showing 1–50 of 153
1 / 4
ELAN Insider Buying Activity
The following table shows recent insider purchases of Elanco Animal Health Incorporated (ELAN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Kurzius Lawrence Erik | director | Buy | 40,000 | $23.40 | $935.9K | 188,647+27% |
| Aug 18, 2026 | O'Neill Shiv | officer: GC AND CORP SEC | Buy | 3,998 | $23.58 | $94.3K | 87,832 |
| Aug 13, 2026 | Harrington Michael J | director | Buy | 5,000 | $21.82 | $109.1K | 131,451 |
| Aug 10, 2026 | VanHimbergen Robert M | officer: EVP and CFO | Buy | 4,200 | $23.08 | $96.9K | 137,516 |
| Aug 10, 2026 | Herendeen Paul | director | Buy | 10,000 | $23.69 | $236.8K | 111,687 |
| May 19, 2026 | Modi Rajeev A. | officer: SEE REMARKS | Buy | 4,911 | $20.35 | $99.9K | 160,812 |
| May 19, 2026 | Simmons Jeffrey N | director, officer: PRESIDENT, CEO AND DIRECTOR | Buy | 4,971 | $20.09 | $99.8K | 171,971 |
| Dec 12, 2025 | Kurzius Lawrence Erik | Director | Buy | 10,000 | $21.30 | $213.0K | 0 |
| Dec 11, 2025 | Modi Rajeev A. | SEE REMARKS | Buy | 4,500 | $21.33 | $96.0K | 0 |
| Dec 11, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 22,000 | $21.75 | $478.5K | 0 |
| Dec 11, 2025 | VanHimbergen Robert M | EVP and CFO | Buy | 6,950 | $21.64 | $150.4K | 0 |
| Mar 7, 2025 | Kurzius Lawrence Erik | Director | Buy | 20,000 | $10.55 | $211.0K | 0 |
| Mar 5, 2025 | HOOVER R DAVID | Director | Buy | 25,000 | $10.90 | $272.6K | 0 |
| Aug 22, 2024 | Harrington Michael J | Director | Buy | 3,500 | $14.85 | $52.0K | 81,094 |
| Aug 12, 2024 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Buy | 100,000 | $13.01 | $1.30M | 145,000+222% |
| May 21, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.98 | $254.7K | 76,330 |
| Mar 8, 2024 | DOYLE WILLIAM F | Director | Buy | 15,000 | $16.30 | $244.5K | 61,330+32% |
| Mar 8, 2024 | Harrington Michael J | Director | Buy | 3,100 | $16.29 | $50.5K | 77,594 |
| Mar 6, 2024 | HOOVER R DAVID | Director | Buy | 20,000 | $16.14 | $322.8K | 185,000 |
ELAN Insider Selling Activity
The following table shows recent insider sales of Elanco Animal Health Incorporated (ELAN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Bettington Timothy J | officer: SEE REMARKS | Sell | 4,350 | $23.00 | $100.0K | 138,911 |
| Jul 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,346 | $14.64 | $63.6K | 0 |
| Jul 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,161 | $14.64 | $17.0K | 0 |
| Apr 3, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 23,558 | $9.72 | $229.0K | 0 |
| Mar 1, 2025 | Bettington Timothy J | SEE REMARKS | Sell | 3,514 | $11.17 | $39.3K | 0 |
| Mar 1, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 11,749 | $11.17 | $131.2K | 0 |
| Mar 1, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 4,747 | $11.17 | $53.0K | 0 |
| Mar 1, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 15,049 | $11.17 | $168.1K | 0 |
| Mar 1, 2025 | Kinard David S | SEE REMARKS | Sell | 7,162 | $11.17 | $80.0K | 0 |
| Mar 1, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 3,430 | $11.17 | $38.3K | 0 |
| Mar 1, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,356 | $11.17 | $26.3K | 0 |
| Mar 1, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 6,557 | $11.17 | $73.2K | 0 |
| Mar 1, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 3,879 | $11.17 | $43.3K | 0 |
| Mar 1, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 75,721 | $11.17 | $845.8K | 0 |
| Mar 1, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 18,196 | $11.17 | $203.2K | 0 |
| Feb 19, 2025 | Cabral Ramiro Martin | SEE REMARKS | Sell | 30,093 | $11.24 | $338.2K | 207,169 |
| Feb 19, 2025 | Correia de Simas Jose Manuel | SEE REMARKS | Sell | 11,808 | $11.24 | $132.7K | 64,042 |
| Feb 19, 2025 | de Brabander Ellen | SEE REMARKS | Sell | 69,916 | $11.24 | $785.9K | 186,214-27% |
| Feb 19, 2025 | Kinard David S | SEE REMARKS | Sell | 17,968 | $11.24 | $202.0K | 173,935 |
| Feb 19, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 2,596 | $11.24 | $29.2K | 55,641 |
| Feb 19, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 2,691 | $11.24 | $30.2K | 49,462 |
| Feb 19, 2025 | Modi Rajeev A. | SEE REMARKS | Sell | 18,737 | $11.24 | $210.6K | 94,619 |
| Feb 19, 2025 | O'Neill Shiv | GC AND CORP SEC | Sell | 2,943 | $11.24 | $33.1K | 26,849 |
| Feb 19, 2025 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | Sell | 195,840 | $11.24 | $2.20M | 1,612,848 |
| Feb 19, 2025 | YOUNG TODD S. | SEE REMARKS | Sell | 46,045 | $11.24 | $517.5K | 159,062 |
| Jan 3, 2025 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 351 | $11.98 | $4.2K | 50,212 |
| Jan 3, 2025 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 414 | $11.98 | $5.0K | 48,773 |
| Jul 3, 2024 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | Sell | 4,345 | $14.13 | $61.4K | 50,563 |
| Jul 3, 2024 | Meer James M | CHIEF ACCOUNTING OFFICER | Sell | 1,160 | $14.13 | $16.4K | 49,187 |
| Apr 3, 2024 | Bettington Timothy J | SEE REMARKS | Sell | 23,557 | $15.43 | $363.5K | 106,387 |
| Apr 1, 2024 | Modi Rajeev A. | SEE REMARKS | Sell | 7,509 | $15.97 | $119.9K | 69,763 |
ELAN Insiders
Similar Stocks to ELAN
AMRX
Amneal Pharmaceuticals, Inc.
$21.51+0.28%
$6.87B
INDV
Indivior Pharmaceuticals Inc
$35.37+0.99%
$4.41B
ANIP
ANI Pharmaceuticals, Inc.
$72.00-1.17%
$1.65B
PCRX
Pacira BioSciences, Inc.
$36.40+0.03%
$1.45B
ETON
Eton Pharmaceuticals, Inc.
$52.18-2.78%
$1.43B
HROW
Harrow Health, Inc.
$28.28-5.70%
$1.09B
AMPH
Amphastar Pharmaceuticals, Inc.
$27.43+1.93%
$1.09B
AQST
Aquestive Therapeutics, Inc.
$3.88-3.84%
$507.1M